Cargando…
Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial
INTRODUCTION: Methotrexate (MTX) is an immunosuppressive and anti-inflammatory drug used to treat rheumatoid arthritis (RA) and other autoimmune conditions. MTX is transported into cells, where glutamate moieties are added and is retained as methotrexate polyglutamates (MTXPGs). In the RA literature...
Autores principales: | Pasnoor, Mamatha, Heim, Andrew J., Herbelin, Laura, Statland, Jeffrey, Dimachkie, Mazen M., Becker, Mara, Barohn, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Kansas Medical Center
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106996/ https://www.ncbi.nlm.nih.gov/pubmed/32256969 |
Ejemplares similares
-
Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN
por: Brown, Alexandra R., et al.
Publicado: (2023) -
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
por: Brown, Alexandra R., et al.
Publicado: (2016) -
Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study
por: Rivner, Michael H., et al.
Publicado: (2020) -
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
por: Guptill, Jeffrey T., et al.
Publicado: (2023) -
Compromised fidelity of B‐cell tolerance checkpoints in AChR and MuSK myasthenia gravis
por: Lee, Jae‐Yun, et al.
Publicado: (2016)